Cagrilintide mimics the action of amylin by binding to amylin receptors in the brain, thus promoting a feeling of fullness and potentially leading to a decrease in food intake. It also slows down gastric emptying and influences metabolic pathways related to glucose control, potentially offering a multifaceted approach to weight management.
All products offered are solely for research and development purposes, not for human or animal consumption, medical, or therapeutic applications. Our products should not be misconstrued or substituted as prescription drugs. We do not dispense any prescription medications and are not a pharmacy. The US Food and Drug Administration has not assessed the assertions made on our website. Products are not intended to diagnose, treat, cure, or prevent any medical conditions or diseases.
